CUV 3.92% $15.65 clinuvel pharmaceuticals limited

Ann: Presentation Goldman Sachs Emerging Leaders Conference, page-15

  1. 1,640 Posts.
    lightbulb Created with Sketch. 56
    Yep, if you're basing your research on PE then... especially in this sector, lot of forward thinking/pricing in consideration
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.